Form 4: ProAssurance Corp Merger Completes, Director Stock Vested

ProAssurance Corporation's merger with The Doctors Company has been finalized, resulting in the conversion of director deferred stock into cash payments.

Summary

• Fabiola Cobarrubias, a Director at ProAssurance Corporation, has reported changes in beneficial ownership following the company's merger.
• The merger, effective June 26, 2026, involved ProAssurance Corporation, The Doctors Company, and Jackson Acquisition Corporation.
• As part of the merger, ProAssurance Corporation became a wholly owned subsidiary of The Doctors Company.
• Deferred shares held by directors, including those awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan, were converted into cash.
• The cash payout for each ProAssurance Corporation common share was $25.00, without interest, subject to withholding taxes.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on the completion of a merger and the resulting cash payouts, rather than new operational or financial performance indicators.

Positives

• The merger has been successfully completed, indicating a significant strategic event for ProAssurance Corporation.
• Director deferred stock compensation plans have been settled through cash payouts, providing liquidity to participants.
• The transaction provides a clear cash consideration of $25.00 per share for ProAssurance Corporation common stock.

Negatives

• The company's status as an independent entity has concluded, as it is now a wholly owned subsidiary.
• Shareholders and participants in deferred stock plans will receive cash, ending their direct equity participation in ProAssurance Corporation.

Risks

• Potential for tax implications related to the cash conversion of deferred shares and common stock.
• Integration risks associated with ProAssurance Corporation becoming a subsidiary of The Doctors Company.

Future Outlook

The filing primarily reports on a completed merger and the subsequent conversion of equity into cash. No specific future financial guidance or outlook for the combined entity is provided in this Form 4.

Industry Context

StockSavvy.ai notes that this Form 4 filing signifies the completion of a significant M&A event in the insurance sector, specifically involving specialty insurance providers. The conversion of equity to cash for directors is a standard outcome in such transactions.

Stakeholder Impact

• Shareholders: Will receive $25.00 per share in cash, ending their equity ownership in ProAssurance Corporation.
• Directors: Have had their deferred stock awards converted into cash payments.
• Employees: May experience changes in reporting structures and benefits as ProAssurance becomes a subsidiary.

Next Steps

• ProAssurance Corporation will operate as a wholly owned subsidiary of The Doctors Company.
• Shareholders and participants in deferred stock plans will receive their cash consideration.

Key Dates

Keywords

ProAssurance Corporation, Merger, Form 4, Director, Deferred Stock, SEC Filing, Beneficial Ownership, The Doctors Company, Cash Consideration